179 related articles for article (PubMed ID: 35661841)
21. Oocyte vitrification versus ovarian cortex transplantation in fertility preservation for adult women undergoing gonadotoxic treatments: a prospective cohort study.
Diaz-Garcia C; Domingo J; Garcia-Velasco JA; Herraiz S; Mirabet V; Iniesta I; Cobo A; Remohí J; Pellicer A
Fertil Steril; 2018 Mar; 109(3):478-485.e2. PubMed ID: 29428307
[TBL] [Abstract][Full Text] [Related]
22. Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.
Creux H; Monnier P; Son WY; Buckett W
J Assist Reprod Genet; 2018 Apr; 35(4):583-592. PubMed ID: 29502188
[TBL] [Abstract][Full Text] [Related]
23. Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours.
Khiat S; Provansal M; Bottin P; Saias-Magnan J; Metzler-Guillemain C; Courbiere B
Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():65-70. PubMed ID: 32784054
[TBL] [Abstract][Full Text] [Related]
24. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
25. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer.
Oktay K; Turan V; Bedoschi G; Pacheco FS; Moy F
J Clin Oncol; 2015 Aug; 33(22):2424-9. PubMed ID: 26101247
[TBL] [Abstract][Full Text] [Related]
26. Probability of live birth after IVF/ICSI treatments in female early onset cancer survivors: a Finnish population-based registry study.
Melin J; Tiitinen A; Hirvonen E; Malila N; Pitkäniemi J; Gissler M; Madanat-Harjuoja L
Hum Reprod; 2021 Nov; 36(12):3131-3140. PubMed ID: 34491339
[TBL] [Abstract][Full Text] [Related]
27. The Experience of Fertility Preservation in a Single Tertiary Center in Korea.
Choi YJ; Hong YH; Kim S; Kim SK; Lee JR; Suh CS
Front Endocrinol (Lausanne); 2022; 13():845051. PubMed ID: 35518927
[TBL] [Abstract][Full Text] [Related]
28. Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy.
D'Hondt C; Vanhoeij M; Van Moer E; Segers I; Fontaine C; Tournaye H; De Vos M
Breast Cancer Res Treat; 2020 Nov; 184(2):433-444. PubMed ID: 32794060
[TBL] [Abstract][Full Text] [Related]
29. Reproductive outcomes after in vitro fertilization treatment in a cohort of Danish women transplanted with cryopreserved ovarian tissue.
Dueholm Hjorth IM; Kristensen SG; Dueholm M; Humaidan P
Fertil Steril; 2020 Aug; 114(2):379-387. PubMed ID: 32624219
[TBL] [Abstract][Full Text] [Related]
30. Value of early referral to fertility preservation in young women with breast cancer.
Lee S; Ozkavukcu S; Heytens E; Moy F; Oktay K
J Clin Oncol; 2010 Nov; 28(31):4683-6. PubMed ID: 20876425
[TBL] [Abstract][Full Text] [Related]
31. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
[TBL] [Abstract][Full Text] [Related]
32. FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER.
Vuković P; Kasum M; Raguž J; Lonjak N; Bilić Knežević S; Orešković I; Beketić Orešković L; Čehić E
Acta Clin Croat; 2019 Mar; 58(1):147-156. PubMed ID: 31363337
[TBL] [Abstract][Full Text] [Related]
33. Oocyte vitrification as an efficient option for elective fertility preservation.
Cobo A; García-Velasco JA; Coello A; Domingo J; Pellicer A; Remohí J
Fertil Steril; 2016 Mar; 105(3):755-764.e8. PubMed ID: 26688429
[TBL] [Abstract][Full Text] [Related]
34. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
[TBL] [Abstract][Full Text] [Related]
35. The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival.
Greer AC; Lanes A; Poorvu PD; Kennedy P; Thomas AM; Partridge AH; Ginsburg ES
Cancer; 2021 Oct; 127(20):3872-3880. PubMed ID: 34161610
[TBL] [Abstract][Full Text] [Related]
36. [Live birth rates after breast cancer among women who desired a child].
Charpentier P; Cavalieri M; Desmoulins I; Coutant C
Bull Cancer; 2024 May; 111(5):463-472. PubMed ID: 38580527
[TBL] [Abstract][Full Text] [Related]
37. Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?
Lee S; Oktay K
Fertil Steril; 2012 Oct; 98(4):961-4.e1. PubMed ID: 22771027
[TBL] [Abstract][Full Text] [Related]
38. [Oncofertility and breast cancer at Montpellier University Hospital: Retrospective analysis of patients management since 2011].
du Boulet B; Bringer-Deutsch S; Anahory T; Ferrières A; Loup Cabaniols V; Duraes M; Huberlant S; Ranisavljevic N
Gynecol Obstet Fertil Senol; 2021 Feb; 49(2):112-121. PubMed ID: 33130043
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes in cancer patients who did or did not pursue fertility preservation.
Moravek MB; Confino R; Smith KN; Kazer RR; Klock SC; Lawson AK; Gradishar WJ; Pavone ME
Fertil Steril; 2018 Feb; 109(2):349-355. PubMed ID: 29338854
[TBL] [Abstract][Full Text] [Related]
40. Fertility-sparing surgery and fertility preservation in cervical cancer: The desire for parenthood, reproductive and obstetric outcomes.
van der Plas RCJ; Bos AME; Jürgenliemk-Schulz IM; Gerestein CG; Zweemer RP
Gynecol Oncol; 2021 Dec; 163(3):538-544. PubMed ID: 34583837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
